{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:39:20Z","timestamp":1770989960230,"version":"3.50.1"},"reference-count":72,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Data"],"abstract":"<jats:p>Immunomics tools and databases play an important role in the designing of prophylactic or therapeutic vaccines against pathogenic bacteria and viruses. Therefore, we aimed to illustrate the different immunological databases and web servers used to design a chimeric vaccine candidate against human cervix papilloma. Initially, cellular immunity inducing major histocompatibility complex class I and II epitopes from L2 protein of papilloma 58 strain were predicted using the IEDB, NetMHC, and Tepi tools. Then, the overlapped segments from the above analysis were used to calculate efficiency on interferon-gamma and humoral immunity production. In addition, the allergenicity, antigenicity, cross-reactivity with human proteomes, and epitope conservancy of elite segments were determined. The chimeric vaccine candidate (SGD58) was constructed with two different overlapped peptide segments (23\u201336) and (29\u201342), adjuvants (flagellin and RS09), two Th epitopes, and amino acid linkers. The results of homology modeling demonstrated that SGD58 have 88.6% of favored regions based on Ramachandran plot. Protein\u2013protein docking with Swarm Dock reveals SGD58 with receptor complex have \u221254.74 kcal\/mol of binding energy with more than 20 interacting residues. Docked complex are stable in 100ns of molecular dynamic simulation. Further, coding sequences of SGD58 also show elevated gene expression in E. coli. In conclusion, SGD58 may prompt vaccine against cervix papilloma. This study provides insight of vaccine design against different pathogenic microbes as well.<\/jats:p>","DOI":"10.3390\/data4010031","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T03:30:08Z","timestamp":1551065408000},"page":"31","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunomics Datasets and Tools: To Identify Potential Epitope Segments for Designing Chimeric Vaccine Candidate to Cervix Papilloma"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-8810","authenticated-orcid":false,"given":"Satyavani","family":"Kaliamurthi","sequence":"first","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-3853","authenticated-orcid":false,"given":"Gurudeeban","family":"Selvaraj","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"}]},{"given":"Sathishkumar","family":"Chinnasamy","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang, Shanghai 200240, China"}]},{"given":"Qiankun","family":"Wang","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang, Shanghai 200240, China"}]},{"given":"Asma Sindhoo","family":"Nangraj","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang, Shanghai 200240, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-4586","authenticated-orcid":false,"given":"William C.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong"}]},{"given":"Keren","family":"Gu","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-7502","authenticated-orcid":false,"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou High-tech Industrial Development Zone, 100 Lianhua Street, Zhengzhou 450001, China"},{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang, Shanghai 200240, China"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.4049\/jimmunol.1490012","article-title":"Development and implementation of papillomavirus prophylactic vaccines","volume":"192","author":"Frazer","year":"2014","journal-title":"J. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2009.06.008","article-title":"Oncogenic activities of human papillomaviruses","volume":"143","author":"Munger","year":"2009","journal-title":"Virus Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2013.06.004","article-title":"Human papillomaviruses and cancer","volume":"108","author":"Haedicke","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00705-017-3556-1","article-title":"Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China","volume":"163","author":"Tao","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","article-title":"Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity","volume":"14","author":"Kenter","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-012-1292-7","article-title":"A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions","volume":"61","author":"Ramwadhdoebe","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_8","first-page":"441","article-title":"Cervical Cancer Screening","volume":"97","author":"Rerucha","year":"2018","journal-title":"Am. Fam. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hong, Y., Zhang, C., Li, X., Lin, D., and Liu, Y. (2013). HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health, 13.","DOI":"10.1186\/1471-2458-13-696"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jinf.2018.02.008","article-title":"Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review","volume":"76","author":"Zhou","year":"2018","journal-title":"J. Infect."},{"key":"ref_12","first-page":"412","article-title":"Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening","volume":"15","author":"You","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","article-title":"HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix","volume":"15","author":"Long","year":"2018","journal-title":"Virol. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13027-018-0211-8","article-title":"Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer","volume":"13","author":"Zhang","year":"2018","journal-title":"Infect. Agent. Cancer"},{"key":"ref_15","first-page":"e22581","article-title":"Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China","volume":"32","author":"Dai","year":"2018","journal-title":"Cancer Med."},{"key":"ref_16","first-page":"204","article-title":"Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China","volume":"18","author":"Zhao","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhong, Z., Hou, J., Lin, L., Weng, R., Su, L., Lei, N., Hou, T., Yang, H., and Li, K. (2017). Analysis of HPV distribution in patients with cervical precancerous lesions in Western China. BMC Infect. Dis., 96.","DOI":"10.1097\/MD.0000000000007304"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.12659\/MSM.905789","article-title":"The Genotype of Human Papillomavirus and Associated Factors Among High Risk Males in Shanghai, China: A Molecular Epidemiology Study","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_19","unstructured":"(2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep., 59, 626\u2013629."},{"key":"ref_20","unstructured":"(2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb. Mortal. Wkly. Rep., 60, 1705\u20131708."},{"key":"ref_21","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Paz-Zulueta, M., Alvarez-Paredes, L., Rodriguez Diaz, J.C., Paras-Bravo, P., Andrada Becerra, M.E., Rodriguez Ingelmo, J.M., Ruiz Garcia, M.M., Portilla, J., and Santibanez, M. (2018). Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4033-2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14760584.2016.1157479","article-title":"Progress and prospects for L2-based human papillomavirus vaccines","volume":"15","author":"Jiang","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.18388\/abp.2014_1875","article-title":"Virus-like particles as vaccine","volume":"61","author":"Chroboczek","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0253-7184.85409","article-title":"Human papilloma virus vaccines: Current scenario","volume":"32","author":"Pandhi","year":"2011","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"key":"ref_26","first-page":"97","article-title":"Cervarix: A vaccine for the prevention of HPV 16, 18-associated cervical cancer","volume":"2","author":"Monie","year":"2008","journal-title":"Biologics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.03.020","article-title":"Ten years of HPV vaccines: State of art and controversies","volume":"102","author":"Angioli","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.2009.13","article-title":"Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection","volume":"87","author":"Karanam","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the minor capsid protein of papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/viro.1995.1392","article-title":"Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4","volume":"211","author":"Chandrachud","year":"1995","journal-title":"Virology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/0022-1317-77-7-1577","article-title":"Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies","volume":"77","author":"Gaukroger","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.2174\/138161282432190109105339","article-title":"Computational Perspective on the Current State of the Methods and New Challenges in Cancer Drug Discovery","volume":"24","author":"Wei","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.2174\/1381612824666181106094133","article-title":"Cancer Immunoinformatics: A Promising Era in the Development of Peptide Vaccines for Human Papillomavirus-induced Cervical Cancer","volume":"24","author":"Kaliamurthi","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","first-page":"107","article-title":"Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus","volume":"12","author":"Kaliamurthi","year":"2018","journal-title":"Biologics"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kaliamurthi, S., Selvaraj, G., Chinnasamy, S., Wang, Q., Nangraj, A.S., Cho, W., Gu, K., and Wei, D.Q. (2019). Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology. Viruses, 11.","DOI":"10.3390\/v11010063"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"(2017). UniProt: The universal protein knowledgebase. Nucleic Acids Res., 45, D158\u2013D169.","DOI":"10.1093\/nar\/gkw1099"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1744-313X.2006.00637.x","article-title":"Allelic distribution of HLA class I genes in the Tibetan ethnic population of China","volume":"33","author":"Chen","year":"2006","journal-title":"Int. J. Immunogenet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.humimm.2007.02.006","article-title":"Origin of Tibeto-Burman speakers: Evidence from HLA allele distribution in Lisu and Nu inhabiting Yunnan of China","volume":"68","author":"Chen","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.humimm.2007.09.006","article-title":"Human leukocyte antigen class I polymorphism in Miao, Bouyei, and Shui ethnic minorities of Guizhou, China","volume":"68","author":"Chen","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.7314\/APJCP.2014.15.17.7333","article-title":"Prevalence and genotype distribution of human papillomavirus among women from Henan, China","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12985-014-0202-3","article-title":"The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China","volume":"11","author":"Zhang","year":"2014","journal-title":"Virol. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lu, J.F., Shen, G.R., Li, Q., Chen, X., Ma, C.F., and Zhu, T.H. (2017). Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2328-6"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wang, Y., and Xue, J. (2018). Distribution and role of high-risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China. Cancer Med.","DOI":"10.1002\/cam4.1559"},{"key":"ref_45","first-page":"D405","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Dai","year":"2015","journal-title":"Cancer Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","article-title":"Prediction of CTL epitopes using QM, SVM and ANN techniques","volume":"22","author":"Bhasin","year":"2004","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"W254","DOI":"10.1093\/nar\/gkr434","article-title":"PAComplex: A web server to infer peptide antigen families and binding models from TCR-pMHC complexes","volume":"39","author":"Liu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wang, P., Sidney, J., Dow, C., Mothe, B., Sette, A., and Peters, B. (2008). A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol., 4.","DOI":"10.1371\/journal.pcbi.1000048"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"18.19.1","DOI":"10.1002\/cpim.12","article-title":"TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2\u2014A server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: Allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"El-Manzalawy, Y., Dobbs, D., and Honavar, V. (2012, January 7\u201310). Predicting protective bacterial antigens using random forest classifiers. Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine, Orlando, FL, USA.","DOI":"10.1145\/2382936.2382991"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/bioinformatics\/btt484","article-title":"A fast Peptide Match service for UniProt Knowledgebase","volume":"29","author":"Chen","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bui, H.H., Sidney, J., Li, W., Fusseder, N., and Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-361"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: Accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Walker, J.M. (2005). Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook, Humana Press.","DOI":"10.1385\/1592598900"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Doytchinova, I.A., and Flower, D.R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-4"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-40"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bhattacharya, D., and Cheng, J. (2013). i3Drefine software for protein 3D structure refinement and its assessment in CASP10. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069648"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: Phi,psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: Patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kringelum, J.V., Lundegaard, C., Lund, O., and Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Comput. Biol., 8.","DOI":"10.1371\/journal.pcbi.1002829"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/bioinformatics\/btt038","article-title":"SwarmDock: A server for flexible protein-protein docking","volume":"29","author":"Torchala","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: The European molecular biology open software suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet."},{"key":"ref_71","unstructured":"(2018, October 01). The GenScript Rare Codon Analysis. Available online: https:\/\/www.genscript.com\/tools\/rare-codon-analysis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kaliamurthi, S., Selvaraj, G., and Wei, D.Q. (2018). Immunomics datasets: To identify potential candidates for chimeric vaccine design to cervix papilloma [Data set]. Zenodo.","DOI":"10.3390\/data4010031"}],"container-title":["Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5729\/4\/1\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:32:27Z","timestamp":1760185947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5729\/4\/1\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["data4010031"],"URL":"https:\/\/doi.org\/10.3390\/data4010031","relation":{},"ISSN":["2306-5729"],"issn-type":[{"value":"2306-5729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}